● Covered by 1 source · 1 reportMedium impact1 neutral
Simile Raises $200M Series B at $2B Valuation for Synthetic User Technology
Key points
- Simile raised $200 million in Series B funding.
- The funding round values the company at $2 billion.
- Greenoaks led the Series B, with participation from several other firms.
- Simile provides simulated users for marketing and product research.
Simile Secures Significant Series B Funding
Simile, a startup focused on synthetic user technology, has announced the closure of a $200 million Series B funding round. This investment places the company's valuation at $2 billion. The Series B was led by Greenoaks, with additional participation from Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition, and CVS Health Ventures. CVS is also a customer of Simile.
Rapid Growth Since Series A
This latest funding round comes only five months after Simile emerged from stealth and completed its $100 million Series A round, which was led by Index Ventures. The rapid succession of funding rounds indicates strong investor confidence in Simile's technology and market potential within the AI sector.
Synthetic Users for Research
Simile's core offering involves providing simulated users for applications such as marketing and product research. The company was founded by Joon Sung Park, whose doctoral research at Stanford included a project called “Smallville,” which explored AI agents simulating human lives. This technology aims to offer new methods for understanding user interactions and market responses.
Market Context and Impact
The investment in Simile reflects a broader trend of venture capital interest in AI-driven simulation and research tools. While the concept of simulating all human behavior is noted as ambitious, the application of synthetic users for specific research purposes is considered a promising area. Other companies in this space, such as Aaru, have also recently secured significant funding, indicating a growing niche for AI-powered research solutions.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
Reporting from
Simile, a startup specializing in synthetic users for market and product research, secured $200 million in Series B funding, bringing its valuation to $2 billion. This funding round occurred just five months after its $100 million Series A, indicating rapid investor interest in AI-driven simulation technologies for research. The investment highlights continued venture capital focus on AI applications that offer new approaches to understanding user behavior and market dynamics.